Inventor · disambiguated record
Victor Gurewich
Also filed as: GUREWICH VICTOR
10 granted patents·8 pending applications·668 citations·filing 1980–2018
90Inventor score
Files withTHROMBOLYTIC SCIENCE INC5GUREWICH VICTOR3FFE THERAPEUTICS LLC2NEW ENGLAND DEACONESS HOSPITAL2THROMBOLYTIC SCIENCE LLC2
Top patents by PatentIndex Score
18 records- 0194US5759542ACompositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseasesNEW ENGLAND DEACONESS HOSPITAL·Filed 1994·Granted Jun 2, 1998·532 cites·11 claims
- 0286US7837992B2C-1 inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysisBETH ISRAEL HOSPITAL·Filed 2007·Granted Nov 23, 2010·12 cites·10 claims
- 0379US7074401B2Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clotsTHROMBOLYTIC SCIENCE INC·Filed 2004·Granted Jul 11, 2006·11 cites·6 claims
- 0477US5472692APro-urokinase mutantsNEW ENGLAND DEACONESS HOSPITAL·Filed 1993·Granted Dec 5, 1995·52 cites·9 claims
- 0575US8187592B2C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysisGUREWICH VICTOR·Filed 2010·Granted May 29, 2012·5 cites·6 claims
- 0670US11213574B2Methods for safe and effective thrombolysis using sequential administration of tissue plasminogen activator and mutant pro-urokinaseTHROMBOLYTIC SCIENCE LLC·Filed 2015·Granted Jan 4, 2022·1 cites·8 claims
- 0764US2009136557A1Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing ClotsTHROMBOLYTIC SCIENCE INC·Filed 2008·Application pending·0 cites
- 0863US2009226413A1Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing ClotsTHROMBOLYTIC SCIENCE INC·Filed 2008·Application pending·0 cites
- 0962US4381346AIsolation of plasminogen activators useful as therapeutic and diagnostic agentsHUASIN SYED S·Filed 1980·Granted Apr 26, 1983·31 cites·10 claims
- 1062US2009226410A1Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing ClotsTHROMBOLYTIC SCIENCE INC·Filed 2008·Application pending·0 cites
- 1158US2010143325A1Composition And Methods Involving Thrombolytic AgentsVASCULAR LAB·Filed 2008·Application pending·0 cites
- 1257US5626841AUse of intra-platelet urokinase-type plasminogen activators for long-term inhibition of thrombosisFiled 1994·Granted May 6, 1997·24 cites·13 claims
- 1357US2007148160A1Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clotsTHROMBOLYTIC SCIENCE INC·Filed 2006·Application pending·0 cites
- 1455US10081673B2Compositions and methods for treating angiogenesis-related disordersFFE THERAPEUTICS LLC·Filed 2014·Granted Sep 25, 2018·0 cites·23 claims
- 1553US2009010916A1C-1 Inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysisGUREWICH VICTOR·Filed 2008·Application pending·0 cites
- 1652US2019241647A1Compositions And Methods For Treating Angiogenesis-Related DisordersFFE THERAPEUTICS LLC·Filed 2018·Application pending·0 cites
- 1747US11154596B2Methods for thrombolysisTHROMBOLYTIC SCIENCE LLC·Filed 2018·Granted Oct 26, 2021·0 cites·20 claims
- 1834US2013085111A1Production of human c1 inhibitor in human cellsGUREWICH VICTOR·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Victor Gurewich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →